Aurinia Pharmaceuticals Inc (AUPH): Nilai pasar

The market price action of Aurinia Pharmaceuticals (AUPH) reflects the dynamics of a company with capital totaling 2.25. Business growth is driven by the global rollout of Lupkynis and cost-cutting measures aimed at facilitating an acquisition. Production cycles via contractors remain stable and meet all demand. The strategy relies on the expansion of renal pathology therapies and the pursuit of new therapeutic directions.

Aurinia Pharmaceuticals Inc. - Nilai pasar AUPH (periode 04.07.2022 - 22.10.2026)

Rincian metrik komprehensif lan analitis Aurinia Corp (AUPH)

Indikator keuangan lan pasar perusahaan Aurinia Pharmaceuticals (AUPH):

Kutipan saham Aurinia Pharmaceuticals Inc.|AUPH - Prakiraan konsensus analis|Nilai pasar Aurinia Corp

Analisis fundamental perusahaan:AUPH (Aurinia Pharmaceuticals Inc.)

Sampel barang Aurinia Corp

Market capitalization represents the aggregate value of all outstanding shares, calculated as the product of the current closing price and the total shares issued to assess the asset's market weight. By analyzing the dynamics of the company's full market value, an investor can evaluate the price reaction to the scaling of Lupkynis sales, international expansion, and the probability of Aurinia Pharmaceuticals (AUPH) being acquired by a strategic buyer.

Pesaing wigati

argenx - Biji pasar|Kapitalisasi pasar BioNTech Inc. BNTX|ABVX - Nilai pasar|Biji pasar ADMA|PTGX: Kapitalisasi pasar|immunovant.com - Nilai pasar|Nilai pasar Kiniksa|Grifols SA - Biji pasar|Kapitalisasi pasar ADPT|CLDX (Celldex Corp) - Nilai pasar|Kapitalisasi pasar BCRX (BioCryst)|Kapitalisasi pasar veratx.com VERA|DNTH - Nilai pasar|Nilai pasar PHVS (Pharvaris NV)|AbCellera (ABCL) - Nilai pasar|Biji pasar Tourmaline|PGEN (Precigen, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar pharming.com|Biji pasar NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Nilai pasar|Kapitalisasi pasar ZBIO (Zenas Biopharma, Inc.)|Kapitalisasi pasar Immunome Bio (IMNM)|GOSS - Nilai pasar|kalvista.com (KALV) - Biji pasar|Septerna (SEPN) - Nilai pasar|Biji pasar Pieris Pharma|Biji pasar SVRA|Kapitalisasi pasar Rigel Corp|Nilai pasar AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalisasi pasar|Kapitalisasi pasar ENGN (enGene)|rapt.com (RAPT) - Nilai pasar|Aerovate - Kapitalisasi pasar|ACRS - Kapitalisasi pasar|KYTX (Kyverna Therapeutics) - Biji pasar|tizianalifesciences.com (TLSA) - Kapitalisasi pasar|Nilai pasar Cabaletta Bio|VTYX: Nilai pasar|Kapitalisasi pasar THTX|Kapitalisasi pasar Avalo Therapeutics Inc|Nilai pasar Eledon Pharmaceuticals ELDN|AGEN: Kapitalisasi pasar|Climb Bio - Kapitalisasi pasar|Kapitalisasi pasar zurabio.com ZURA|ATYR: Kapitalisasi pasar|Adagene Inc. (ADAG) - Kapitalisasi pasar|Biji pasar IMA|STTK: Nilai pasar|Nilai pasar Equillium, Inc. (EQ)|CNTB: Biji pasar|Kapitalisasi pasar IMUX (Immunic)|Nilai pasar ATRA|InflaRx GmbH - Kapitalisasi pasar|XFOR - Kapitalisasi pasar|adicetbio.com (ACET) - Nilai pasar|Celularity - Nilai pasar|Nilai pasar INmune Bio Corp|Biji pasar Barinthus Biotherapeutics Corp (BRNS)|Kapitalisasi pasar KZR|Kapitalisasi pasar sabbiotherapeutics.com (SABS)|Kapitalisasi pasar AKTX (Akari Therapeutics Plc)|ENLV - Biji pasar|Q32 Bio Corp - Kapitalisasi pasar|Nilai pasar GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Biji pasar|ibioinc.com (IBIO) - Kapitalisasi pasar|Biji pasar CARM|XTLB (XTL Biopharmaceuticals Ltd) - Nilai pasar|Kapitalisasi pasar BOLT|Kapitalisasi pasar hcwbiologics.com|Kapitalisasi pasar APVO (Aptevo Therapeutics Inc.)|AIM - Biji pasar|Aditxt Corp - Kapitalisasi pasar|GRI - Kapitalisasi pasar|XORTX (XRTX) - Nilai pasar|HIND (Vyome Therapeutics) - Nilai pasar|Nilai pasar Revelation Biosciences|indaptusrx.com (INDP) - Kapitalisasi pasar|Kapitalisasi pasar SCNI|Kapitalisasi pasar calcimedica.com (CALI)|Affimed N.V. - Biji pasar|Kapitalisasi pasar Allakos Inc ALLK|HOOK - Nilai pasar|Biji pasar IGMS|ITOS: Kapitalisasi pasar|Ocean Biomedical Inc - Nilai pasar|Nilai pasar TC BioPharm (Holdings) PLC|Third Harmonic Bio Inc - Biji pasar